Works matching IS 17561841 AND DT 2018 AND VI 21 AND IP 2


Results: 32
    1

    Opportunistic infections in patients with idiopathic inflammatory myopathies.

    Published in:
    International Journal of Rheumatic Diseases, 2018, v. 21, n. 2, p. 487, doi. 10.1111/1756-185X.13255
    By:
    • Redondo‐Benito, Ada;
    • Curran, Adrian;
    • Villar‐Gomez, Ana;
    • Trallero‐Araguas, Ernesto;
    • Fernández‐Codina, Andreu;
    • Pinal‐Fernandez, Iago;
    • Rodrigo‐Pendás, Jose Ángel;
    • Selva‐O'Callaghan, Albert
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Two‐year persistence of golimumab as second‐line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real‐life data from the LORHEN registry.

    Published in:
    International Journal of Rheumatic Diseases, 2018, v. 21, n. 2, p. 422, doi. 10.1111/1756-185X.13199
    By:
    • Favalli, Ennio G.;
    • Sinigaglia, Luigi;
    • Becciolini, Andrea;
    • Grosso, Vittorio;
    • Gorla, Roberto;
    • Bazzani, Chiara;
    • Atzeni, Fabiola;
    • Sarzi Puttini, Pier C.;
    • Fusaro, Enrico;
    • Pellerito, Raffaele;
    • Caporali, Roberto
    Publication type:
    Article
    22
    23

    Issue Information.

    Published in:
    International Journal of Rheumatic Diseases, 2018, v. 21, n. 2, p. 357, doi. 10.1111/1756-185X.13164
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32